Orica acquires leading geospatial tools maker Axis Mining Technology
ASX-listed mining company Orica has completed the acquisition of Axis Mining Technology, a manufacturing leader for specialised geospatial tools and instruments for the mining industry.Â
Australian craft brewers ramp up production but are held back by unplanned downtime
Media Release by OFS
Research from OFS shows a 7.6% surge in craft beer production from April to June compared with the previous three...
ReNu Energy invests in Vaulta’s recyclable battery casing technology
ASX-listed company ReNu Energy is expanding its renewable and clean energy portfolio with a $1 million investment in Australian battery casing tech company Vaulta.Â
Quickstep looks to expand Aftermarket unit after review
Quickstep, a leading aerospace composite business in Australia, has decided to keep its Aftermarket business as a core part of the company and is planning to enhance the business through several new growth initiativesÂ
Quickstep collaborative project to reduce composite production cost
Aerospace composite manufacturer Quickstep has collaborated with the Sovereign Manufacturing Automation for Composites CRC (SoMAC CRC) and Deakin University’s Institute for Intelligent Systems Research and Innovation to help address the high cost of large-scale composite production.Â
Hearing aid brand Cochlear sees positive FY 2022 financial results
ASX-listed hearing devices manufacturer Cochlear Limited has reported a record sales revenue of $1.6 billion for the end of fiscal year 2022, a whopping...
Eurozone manufacturing PMI at 48.5 in February
The euro area manufacturing purchasing managers’ index (PMI) stood at 48.5 in February, falling slightly from 48.8 in January, while the manufacturing output index nudged above the neutral mark to reach 50.1, up from 48.9 in January.
Orbital UAV to raise $4M to boost engine development programs
Orbital UAV is raising $4 million through the issue of approximately 28.6 million new fully paid ordinary shares at an issue price of $0.14 per new share to support its existing engine development programs.Â
Immuron prepares for diarrhoea-focused clinical trial as US FDA lifts clinical hold
Immuron, an Australia-based biopharmaceutical company, is slated to move forward with the clinical evaluation of a new oral therapeutic targeting Campylobacter and Enterotoxigenic Escherichia coli (ETEC) following approval from the US Food and Drug Administration (FDA).
DroneShield receives backing from US tech firm Epirus
ASX-listed tech provider DroneShield has received a $3.7 million investment from Epirus through a placement of 18,500,000 fully paid ordinary shares in DroneShield.Â



























